• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动消融术后的数字监测与电子患者报告结局收集

Digital monitoring and electronic patient-reported outcomes collection following atrial fibrillation ablation.

作者信息

Almeida João G, Teixeira Rafael, Neves Inês, Carrington Mafalda, Fonseca Paulo, Oliveira Marco, Gonçalves Helena, Primo João, Fontes-Carvalho Ricardo, Barra Sérgio, Martínez Juan Pablo, Almeida Rute

机构信息

Cardiology Department, Unidade Local de Saúde Gaia Espinho, Vila Nova de Gaia, Portugal.

CINTESIS@RISE, Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.

出版信息

Heart Rhythm O2. 2025 Apr 21;6(7):969-977. doi: 10.1016/j.hroo.2025.04.004. eCollection 2025 Jul.

DOI:10.1016/j.hroo.2025.04.004
PMID:40734743
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12302198/
Abstract

BACKGROUND

Atrial fibrillation (AF) remains a challenging condition to manage traditionally in clinical practice, and despite improvements in digital health, its impact on clinical outcomes remains uncertain.

OBJECTIVE

This study aimed to assess the feasibility of a structured digital-blended follow-up for patients undergoing AF ablation, incorporating electronic patient-reported outcome measures (PROMs) while evaluating its impact on the timing of recurrence diagnosis and reintervention.

METHODS

In this retrospective observational study, we included patients enrolled in a structured 2-year digital program starting in January 2021. This featured a Web platform for physicians to record clinical variables and a patient-centered mobile application to report PROM (Atrial Fibrillation Effect on Quality-of-Life [AFEQT] and Patient-Reported Outcomes Measurement Information System [PROMIS]). Clinical outcomes were compared with those from a retrospective conventionally managed cohort (2017-2020) after propensity score matching (n = 363 per group).

RESULTS

Until May 2024, 421 patients were enrolled (mean age: 60.9 years; 33.0% female). Over a median follow-up of 546 days, 64% of the patients used the application monthly, and completeness rates for AFEQT and PROMIS questionnaires were 80% and 50%, respectively. At 12 months, significant improvements were observed for AFEQT and PROMIS scores (cognitive and physical function, anxiety, and depression). Arrhythmia recurrence significantly influenced the rates of changes for AFEQT, depression, and physical function ( < .05 for interactions). Digital follow-up was associated with a shorter time until atrial tachycardia or AF recurrence (hazard ratio 1.45, = .019) and antiarrhythmic intervention (hazard ratio 1.65, = .022).

CONCLUSION

Systematic electronic PROM collection after AF ablation is feasible in clinical practice. Structured digital-blended integrated care guarantees continuity of AF management and supports earlier detection and treatment of recurrences.

摘要

背景

在临床实践中,心房颤动(AF)的传统管理仍然具有挑战性,尽管数字健康有所改善,但其对临床结局的影响仍不确定。

目的

本研究旨在评估对接受房颤消融术的患者进行结构化数字混合随访的可行性,纳入电子患者报告结局指标(PROMs),同时评估其对复发诊断时间和再次干预的影响。

方法

在这项回顾性观察研究中,我们纳入了从2021年1月开始参加为期2年结构化数字项目的患者。该项目的特点是有一个供医生记录临床变量的网络平台和一个以患者为中心的移动应用程序,用于报告PROM(房颤对生活质量的影响[AFEQT]和患者报告结局测量信息系统[PROMIS])。在倾向得分匹配后(每组n = 363),将临床结局与回顾性传统管理队列(2017 - 2020年)的结局进行比较。

结果

截至2024年5月,共纳入421例患者(平均年龄:60.9岁;33.0%为女性)。在中位随访546天期间,64%的患者每月使用该应用程序,AFEQT和PROMIS问卷的完成率分别为80%和50%。在12个月时,观察到AFEQT和PROMIS评分(认知和身体功能、焦虑和抑郁)有显著改善。心律失常复发显著影响AFEQT、抑郁和身体功能的变化率(交互作用P <.05)。数字随访与心房心动过速或房颤复发的时间缩短相关(风险比1.45,P = 0.019)以及抗心律失常干预相关(风险比1.65,P = 0.022)。

结论

房颤消融术后系统收集电子PROM在临床实践中是可行的。结构化数字混合综合护理可确保房颤管理的连续性,并支持对复发的早期检测和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3604/12302198/8f923bead668/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3604/12302198/d1b02d0a1fe8/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3604/12302198/d71b13e23f94/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3604/12302198/13ae85358fc0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3604/12302198/f309373331c5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3604/12302198/8f923bead668/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3604/12302198/d1b02d0a1fe8/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3604/12302198/d71b13e23f94/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3604/12302198/13ae85358fc0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3604/12302198/f309373331c5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3604/12302198/8f923bead668/gr4.jpg

相似文献

1
Digital monitoring and electronic patient-reported outcomes collection following atrial fibrillation ablation.心房颤动消融术后的数字监测与电子患者报告结局收集
Heart Rhythm O2. 2025 Apr 21;6(7):969-977. doi: 10.1016/j.hroo.2025.04.004. eCollection 2025 Jul.
2
Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.心房颤动和典型心房扑动的根治性导管消融术:系统评价与经济评估
Health Technol Assess. 2008 Nov;12(34):iii-iv, xi-xiii, 1-198. doi: 10.3310/hta12340.
3
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
4
External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis.体外电复律和药物复律治疗心房颤动、心房扑动或房性心动过速的网状 Meta 分析。
Cochrane Database Syst Rev. 2024 Jun 3;6(6):CD013255. doi: 10.1002/14651858.CD013255.pub2.
5
Exercise-based cardiac rehabilitation for adults with atrial fibrillation.基于运动的心房颤动成人心脏康复。
Cochrane Database Syst Rev. 2024 Sep 17;9(9):CD011197. doi: 10.1002/14651858.CD011197.pub3.
6
Electronic Patient-Reported Outcome System Implementation in Outpatient Cardiovascular Care: A Randomized Clinical Trial.门诊心血管护理中电子患者报告结局系统的实施:一项随机临床试验。
JAMA Netw Open. 2025 Jan 2;8(1):e2454084. doi: 10.1001/jamanetworkopen.2024.54084.
7
Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.“口袋里的药丸”策略与偶发性院内治疗或持续性抗心律失常药物治疗相比,用于阵发性心房颤动的系统评价和成本效益评估。
Health Technol Assess. 2010 Jun;14(31):iii-iv, 1-75. doi: 10.3310/hta14310.
8
Effectiveness of systematic screening for the detection of atrial fibrillation.系统性筛查用于检测心房颤动的有效性。
Cochrane Database Syst Rev. 2013 Apr 30(4):CD009586. doi: 10.1002/14651858.CD009586.pub2.
9
Concomitant atrial fibrillation surgery for people undergoing cardiac surgery.心脏手术患者的同期心房颤动手术。
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD011814. doi: 10.1002/14651858.CD011814.pub2.
10
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病自我管理的计算机和移动技术干预措施。
Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2.

本文引用的文献

1
Prognostic impact of diagnosis-to-ablation time on outcomes following catheter ablation in persistent atrial fibrillation and left ventricular systolic dysfunction.持续性心房颤动合并左心室收缩功能障碍患者导管消融术后诊断至消融时间对预后的影响
Heart Rhythm. 2025 Jun;22(6):1429-1436. doi: 10.1016/j.hrthm.2024.09.059. Epub 2024 Sep 27.
2
Pulmonary Vein Isolation vs Sham Intervention in Symptomatic Atrial Fibrillation: The SHAM-PVI Randomized Clinical Trial.症状性心房颤动中肺静脉隔离与假干预对比:SHAM-PVI随机临床试验
JAMA. 2024 Sep 2;332(14):1165-73. doi: 10.1001/jama.2024.17921.
3
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).
2024年欧洲心脏病学会(ESC)心房颤动管理指南,与欧洲心胸外科学会(EACTS)联合制定。
Eur Heart J. 2024 Sep 29;45(36):3314-3414. doi: 10.1093/eurheartj/ehae176.
4
Rising trend in use of patient-reported outcomes in atrial fibrillation clinical trials.心房颤动临床试验中患者报告结局使用的上升趋势。
Heart Rhythm. 2024 Sep;21(9):1524-1525. doi: 10.1016/j.hrthm.2024.04.015. Epub 2024 Apr 9.
5
The Cost of Atrial Fibrillation: A Systematic Review.心房颤动的成本:系统评价。
Value Health. 2024 Apr;27(4):527-541. doi: 10.1016/j.jval.2023.12.015. Epub 2024 Jan 29.
6
Changes in healthcare utilisation during implementation of remote atrial fibrillation management: TeleCheck-AF project.远程心房颤动管理实施期间的医疗保健利用变化:TeleCheck-AF项目。
Neth Heart J. 2024 Mar;32(3):130-139. doi: 10.1007/s12471-023-01836-6. Epub 2024 Jan 12.
7
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2023 ACC/AHA/ACCP/HRS 指南:心房颤动的诊断与管理——美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2024 Jan 2;149(1):e1-e156. doi: 10.1161/CIR.0000000000001193. Epub 2023 Nov 30.
8
Moving Toward PRO-Guided Care of AF.迈向房颤的以患者报告结局为导向的护理
JACC Clin Electrophysiol. 2023 Sep;9(9):1945-1947. doi: 10.1016/j.jacep.2023.07.009. Epub 2023 Aug 23.
9
The usability and effect of an mHealth disease management platform on the quality of life of patients with paroxysmal atrial fibrillation - The emPOWERD-AF study.移动医疗疾病管理平台对阵发性心房颤动患者生活质量的可用性和效果 - emPOWERD-AF 研究。
Health Informatics J. 2022 Oct-Dec;28(4):14604582221139053. doi: 10.1177/14604582221139053.
10
Association of Atrial Fibrillation Burden With Health-Related Quality of Life After Atrial Fibrillation Ablation: Substudy of the Cryoballoon vs Contact-Force Atrial Fibrillation Ablation (CIRCA-DOSE) Randomized Clinical Trial.心房颤动负荷与心房颤动消融后健康相关生活质量的关系:冷冻球囊与接触力指导心房颤动消融(CIRCA-DOSE)随机临床试验的亚研究。
JAMA Cardiol. 2021 Nov 1;6(11):1324-1328. doi: 10.1001/jamacardio.2021.3063.